Hypertension Diagnostics, Inc.
HDII
$0.00
$0.000.00%
| 03/31/2013 | 12/31/2012 | 09/30/2012 | 06/30/2012 | 03/31/2012 | |
|---|---|---|---|---|---|
| Revenue | -95.03% | 7.16% | 181.60% | 127.30% | 115.86% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -95.03% | 7.16% | 181.60% | 127.30% | 115.86% |
| Cost of Revenue | -65.13% | 96.66% | 7,664.14% | 233,814.29% | 2,525.66% |
| Gross Profit | -576.40% | -940.96% | -340.43% | -8,264.29% | -71.61% |
| SG&A Expenses | -36.80% | 85.41% | 160.27% | 267.28% | 96.66% |
| Depreciation & Amortization | 72.00% | 72.00% | 72.00% | 72.00% | 733.33% |
| Other Operating Expenses | 70.16% | 70.16% | 70.16% | 70.16% | -- |
| Total Operating Expenses | -56.38% | 92.73% | 767.57% | 1,164.61% | 842.80% |
| Operating Income | -69.63% | -140.05% | -168.87% | -279.80% | -1,292.48% |
| Income Before Tax | -96.35% | -184.71% | -218.28% | -314.62% | -1,255.39% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -96.35% | -184.71% | -218.28% | -314.62% | -1,255.39% |
| Earnings from Discontinued Operations | 156.34% | 524.02% | 305.95% | -72.54% | -23.95% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -81.81% | 10.22% | -12.77% | -410.90% | -334.72% |
| EBIT | -69.63% | -140.05% | -168.87% | -279.80% | -1,292.48% |
| EBITDA | -62.32% | -122.86% | -146.19% | -256.29% | -1,204.21% |
| EPS Basic | -49.46% | 26.32% | 3.94% | -408.51% | -324.39% |
| Normalized Basic EPS | -63.24% | -130.85% | -165.79% | -276.47% | -1,006.67% |
| EPS Diluted | -28.57% | 11.60% | -36.95% | -480.85% | -407.32% |
| Normalized Diluted EPS | -76.23% | -133.33% | -156.76% | -267.35% | -913.33% |
| Average Basic Shares Outstanding | 17.59% | 18.73% | 14.21% | 9.79% | 5.39% |
| Average Diluted Shares Outstanding | 8.33% | 17.27% | 17.73% | 13.51% | 18.41% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
